Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1

Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1o Prevent the Tumor Recurrence for Hepatocellular Carcinoma After Liver Transplantation: A Randomized Controlled Study

The study is designed to investigate the effect of adjuvant therapy by Sorafenib, Oxaliplatin and S-1 to prevent the tumor recurrence for hepatocellular carcinoma after liver transplantation

Inclusion Criteria:

• hepatocellular carcinoma after liver transplantation
• Major organ (heart, lung and brain) function was normal

Exclusion Criteria:

• Any active infectious process
• The presence of clinically confirmed extrahepatic metastasis
• Postoperative dysfunction of any organ